Tributary Capital Management LLC Acquires 126 Shares of Abbott Laboratories (NYSE:ABT)

Sunday, 24 September 2023, 21:13:20
Tributary Capital Management LLC increased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.7% in the second quarter, according to its most recent filing with the SEC. The fund owned 7,719 shares of the healthcare product maker’s stock after acquiring an additional 126 shares during the period. Tributary Capital Management LLC’s […]
— The AM Reporter

Strategic Wealth Investment Group LLC Grows Stock Position in Abbott Laboratories (NYSE:ABT)

Sunday, 24 September 2023, 20:02:51
… s stock. About Abbott Laboratories (Free Report) Abbott Laboratories , together with its … in four segments: Established Pharmaceutical Products, Diagnostic Products, … The Established Pharmaceutical Products segment provides generic pharmaceuticals for the …
— EIN News Pharmaceuticals

Dietary Supplements Market to grow by USD 61.4 billion between 2022 to 2027, Increasing adoption of healthy eating habits is notably driving the dietary supplements market. – Technavio

Sunday, 24 September 2023, 03:30:00

— Kwhen Finance

Herold Advisors Inc. Decreases Holdings in Abbott Laboratories (NYSE:ABT)

Saturday, 23 September 2023, 17:00:18
… Abbott Laboratories ’s payout ratio is currently 69.62%. Abbott Laboratories Profile (Free Report) Abbott Laboratories … segments: Established Pharmaceutical Products, Diagnostic Products … Pharmaceutical Products segment provides generic pharmaceuticals for …
— EIN News Pharmaceuticals

Abbott Laboratories (NYSE:ABT) Position Lowered by Herold Advisors Inc.

Saturday, 23 September 2023, 16:08:44
Herold Advisors Inc. decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,388 shares of the healthcare product maker’s stock after selling 300 shares during the period. Herold Advisors Inc.’s holdings in […]
— The AM Reporter